Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Pronto Diagnostics Plans to Integrate FDNA’s Phenotypic Analysis Into Its Genetic Tests
March 1, 2018
The article discusses Pronto Diagnostics’ plans to incorporate FDNA’s phenotypic analysis technology into its genetic tests. By leveraging FDNA’s advanced facial recognition capabilities, Pronto aims to enhance the accuracy and efficiency of genetic diagnostics. FDNA’s system uses artificial intelligence to analyze facial features, identifying subtle phenotypic markers associated with various genetic conditions. This integration promises to refine diagnostic processes, making it easier to pinpoint genetic disorders that might be overlooked by traditional methods. The collaboration highlights the growing importance of combining genetic tests with phenotypic data to improve patient outcomes and advance personalized medicine.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…